Skip to content

Homoeopathic treatment of depression

Utility of Individualized Homoeopathic Medicines in Treatment of Moderate Depression: A Prospective, Intervention Clinical Trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035783
Enrollment
50
Registered
2021-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F331- Major depressive disorder, recurrent, moderate

Interventions

Intervention1: Individualised homoeopathic medicines: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies. Each dose consists of 4-6 cane sugar globules m

Sponsors

State National Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from depression, diagnosed as per DSM-V criteria [18] 2. Moderate cases of depression (PHQ9 scores 15 to 19) 3. Patients must not have been taking antidepressants or anxiolytic drugs at the time of inclusion 4. Both male and female patients 5. Age between 18 and 65 years 6. Capability and willingness to give informed consent and to comply with the study procedures 7. Patients who can read English and/or Hindi

Exclusion criteria

Exclusion criteria: 1. Severe (PHQ9 2. Patients with other psychiatric diseases; e. g. schizophrenia or other psychotic disorders, bipolar affective disorder, schizoaffective disorders, alcohol or other substance abuse, eating disorders, psychosis, mania, hypomania or any other Axis I disorder except panic disorder, personality disorders, history of seizures 3. A clinically significant acute or chronic disease that would hinder regular participation in the study 4. Treatment with antipsychotics, antidepressants, sedatives/hypnotics or mood stabilizers four weeks prior to the screening 5. Complementary or alternative treatment used simultaneously to the study (for example acupuncture, phytotherapy, psychotherapy etc.) 6. Homeopathic treatment for any chronic diseases eight weeks prior to study entry 7. Cases suffering from uncontrolled systemic illness or life-threatening infections 8. Self-reported immune-compromised state 9. Pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
Patients Health Questionnaire â?? 9 (PHQ-9)Timepoint: Baseline, 3rd month and 6th month

Secondary

MeasureTime frame
NoneTimepoint: NA

Countries

India

Contacts

Public ContactArvind Kumar Verma

State National Homoeopathic Medical College and Hospital

arvindkr.verma@gov.in7275809725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026